Ophthalmology Research

Ophthalmology Research

Open Access
ISSN: 2639-9482
Case Report

Residual Paralytic Esotropia after Sixth Nerve Palsy: Management with Partial Hummelsheim Transposition Combined with Botulinum Toxin

Authors: Inmaculada Herrero Sánchez, Pablo Tejada González, Edurne de la Cámara Sahuquillo, Ana María Abad Pascua, Javier Ramos Duarte, Luca Bueno Borghi, Cristina Calvo Simón, Javier Ascaso Puyuelo, Juan Ibáñez Alperte, Diana Pérez García, Carla Iglesia Lázaro, Jorge Núñez Bueno, Adrián Arranz Álvarez.

DOI: 10.33425/2639-9482.1064


Abstract

Sixth cranial nerve palsy is a common cause of paralytic strabismus, often leading to esotropia and limitation of abduction. Management of residual esotropia can be particularly challenging in long-standing cases or in patients with previous strabismus surgery.

We report a case of a 63-year-old woman presenting with binocular diplopia and residual esotropia following prior surgery for left sixth nerve palsy. Clinical examination revealed a 20 prism diopter esotropia in primary gaze, severe limitation of abduction, and a compensatory head turn. A partial Hummelsheim transposition combined with intraoperative botulinum toxin injection into the medial rectus muscle was performed. of the compensatory head posture.

In the immediate postoperative period, exotropia with adduction limitation was observed, which gradually improved over time. At 6 months, the patient achieved orthotropia in primary position, with significant improvement in ocular motility and complete resolution of the compensatory head posture.

Partial Hummelsheim transposition combined with botulinum toxin represents an effective and safe option for the management of residual paralytic esotropia, particularly in previously operated patients, as it allows satisfactory ocular alignment while preserving anterior segment circulation.

View / Download PDF
Citation: Inmaculada Herrero Sánchez, Pablo Tejada González, Edurne de la Cámara Sahuquillo, et al. Residual Paralytic Esotropia after Sixth Nerve Palsy: Management with Partial Hummelsheim Transposition Combined with Botulinum Toxin. Ophthalmol Res. 2026; 9(1). DOI: 10.33425/2639-9482.1064
Editor-in-Chief
Fuxiang Zhang
Fuxiang Zhang
Department of Ophthalmology | Downriver Optimeyes Supervision Center-Taylor

View full editorial board →
Journal Metrics
Impact Factor 2.3*
Acceptance Rate 75%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days